We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+24.55%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$8.79B
AUM Growth
+$1.45B
Cap. Flow
-$72.5M
Cap. Flow %
-0.82%
Top 10 Hldgs %
20.48%
Holding
2,420
New
180
Increased
1,163
Reduced
213
Closed
125

Top Buys

Rank Stock Value
1
DXCM icon
DexCom
DXCM
+$8.64M
2
WORK
Slack Technologies, Inc.
WORK
+$7.6M
3
ABBV icon
AbbVie
ABBV
+$7.02M
4
TMUS icon
T-Mobile US
TMUS
+$6.46M
5
OTIS icon
Otis Worldwide
OTIS
+$5.52M

Sector Composition

Rank Sector Weight
1 Technology 21.58%
2 Healthcare 14.02%
3 Financials 12.88%
4 Consumer Discretionary 10.4%
5 Industrials 9.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
L icon
676
Loews
L
$23B
$2.17M 0.02%
63,299
-2,636
-4% -$88.9K
MGM icon
677
MGM Resorts International
MGM
$11.1B
$2.17M 0.02%
128,994
-3,749
-3% -$60.5K
HOG icon
678
Harley-Davidson
HOG
$2.9B
$2.16M 0.02%
90,962
+51,192
+129% +$1.11M
SYNH
679
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$2.16M 0.02%
37,116
-25,156
-40% -$1.35M
EG icon
680
Everest Group
EG
$14B
$2.16M 0.02%
10,458
-54
-0.5% -$10.5K
PNW icon
681
Pinnacle West Capital
PNW
$12.2B
$2.16M 0.02%
29,420
+445
+2% +$33.6K
GT icon
682
Goodyear
GT
$1.78B
$2.16M 0.02%
240,936
+107,442
+80% +$816K
VSH icon
683
Vishay Intertechnology
VSH
$5.11B
$2.15M 0.02%
140,765
+8,426
+6% +$131K
GMED icon
684
Globus Medical
GMED
$11.5B
$2.14M 0.02%
44,933
-31,669
-41% -$1.53M
CRUS icon
685
Cirrus Logic
CRUS
$6.08B
$2.14M 0.02%
34,667
-23,177
-40% -$1.58M
NVAX icon
686
Novavax
NVAX
$1.34B
$2.14M 0.02%
25,623
+10,828
+73% +$414K
JEF icon
687
Jefferies Financial Group
JEF
$12.9B
$2.13M 0.02%
143,569
-3,347
-2% -$44.8K
SRC
688
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
$2.13M 0.02%
61,131
+3,885
+7% +$118K
ALB icon
689
Albemarle
ALB
$15.4B
$2.13M 0.02%
27,573
+242
+0.9% +$16.4K
CIT
690
DELISTED
CIT Group Inc.
CIT
$2.12M 0.02%
102,460
+48,088
+88% +$929K
VVV icon
691
Valvoline
VVV
$4.31B
$2.12M 0.02%
109,880
+1,739
+2% +$29.5K
ICUI icon
692
ICU Medical
ICUI
$4.58B
$2.12M 0.02%
11,505
+469
+4% +$93.2K
WAFD icon
693
WaFd
WAFD
$2.81B
$2.12M 0.02%
78,985
+1,704
+2% +$43.9K
GEL icon
694
Genesis Energy
GEL
$1.92B
$2.12M 0.02%
293,256
MYOK
695
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$2.11M 0.02%
21,842
+3,074
+16% +$256K
SYNA icon
696
Synaptics
SYNA
$4.2B
$2.11M 0.02%
35,037
+1,003
+3% +$62.9K
WHR icon
697
Whirlpool
WHR
$2.79B
$2.11M 0.02%
16,257
-33
-0.2% -$3.78K
RRX icon
698
Regal Rexnord
RRX
$11.4B
$2.1M 0.02%
24,063
+562
+2% +$42.1K
WRB icon
699
W.R. Berkley
WRB
$26.2B
$2.1M 0.02%
82,388
-1,767
-2% -$43.3K
SITE icon
700
SiteOne Landscape Supply
SITE
$4.27B
$2.09M 0.02%
18,375
+606
+3% +$56.3K

Similar funds

MetLife Investment Management's Q2 2020 Portfolio in Review

As of Q2 2020, MetLife Investment Management held 2,420 positions worth $8.79B, up 20% from $7.34B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

MetLife Investment Management's Q2 2020 filing shows 180 new, 1,163 increased, 213 reduced and 125 closed positions. Its largest new stake was DexCom: 96,564 shares worth $9.79M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $143M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • MetLife Investment Management's largest Q2 2020 buy was DexCom: 96,564 shares worth $9.79M.
  • MetLife Investment Management added most to AbbVie in Q2 2020, an estimated $7.02M increase.
  • MetLife Investment Management's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $143M.
  • MetLife Investment Management fully exited Allergan plc in Q2 2020, selling an estimated $15M.
  • MetLife Investment Management's ten largest holdings make up 20% of its $8.79B portfolio in Q2 2020.
  • MetLife Investment Management opened 180 new positions and closed 125 in Q2 2020.
  • MetLife Investment Management's portfolio value rose 20% quarter-over-quarter to $8.79B.

Based on MetLife Investment Management's 13F filing for Q2 2020, filed 14 Aug 2020.